Skip to content

Clinical trials

Alzheimer Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Germany Clear all

202 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20042
20051
20066
200712
200814
200912
20108
20117
201210
20139
201410
201516
201611
20179
20188
20199
20209
20219
20228
20236
20248
202514
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed111
Terminated46
Recruiting20
Unknown status12
Active, not recruiting11
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline15
Hoffmann-La Roche13
Pfizer10
Eli Lilly and Company7
Ludwig-Maximilians - University of Munich7
Novartis Pharmaceuticals7
Charite University, Berlin, Germany6
Janssen Research & Development, LLC6
Biogen5
Bristol-Myers Squibb5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease202
Dementia46
Cognitive Dysfunction24
Neurodegenerative Diseases13
Brain Diseases12
Mental Disorders10
Nervous System Diseases10
Central Nervous System Diseases8
Amyloid Neuropathies, Familial7
Memory Disorders7

Trials

Showing 1 to 25 of 202. Each trial links to its page on Pharma Observatory.

102 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.